TAMs, the most abundant immune cells in TME, exhibit an anti-inflammatory M2 phenotype, which promotes tumor progression and maintains an immunosuppressive TME by secreting anti-inflammatory factors, such as TGF-β, and IL-10 244. This evidence concerns the gene TGFB1 and neoplasm.